Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

SPB Exchange goes to the East

6/20/24 SPBE

Yuzhuralzoloto will place 2-4% of additional issue shares

6/20/24 UGLD

HeadHunter opened Grid for a wide range of users

6/20/24 HEAD

Steppe will produce agricultural machinery

6/20/24 AFKS

X5 Retail Group may re-launch alkomarkets

6/20/24 X5

Novatek plans LNG projects in Vietnam

6/20/24 NVTK

Shareholders of Rosseti Lenenergo approved dividends for 2023

6/19/24 LSNG

Severstal updated the development strategy of Olenegorsk Mining and Processing Division

6/19/24 CHMF

Vysokoye mine produced its first gold

6/19/24 UGLD

Astra will engage in import substitution in the authorities of Khanty-Mansi Autonomous Okrug

6/19/24 ASTR